Skin antisepsis survey in <scp>A</scp>ustralia–<scp>N</scp>ew <scp>Z</scp>ealand neonatal nurseries

Shah, Dharmesh; Tracy, Mark

doi:10.1111/jpc.12274

Cited by 17 publications

(12 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…There was variation in reported decontamination practices, including product selection, application and removal. Most decontamination agents reported contained a CHG based product, comparable with 60-90% CHG use in previous studies (Tamma et al, 2010;Shah and Tracy, 2013). The use of CHG products for patients less than 2-3 months of age remains controversial due to a high rate of skin complications (Ponnusamy et al, 2014).…”

Section: Discussionmentioning

confidence: 55%

“…Evidence for best practice CVC insertion and management significantly outweighs PIVC management (Shah and Tracy, 2013;Sharpe et al, 2016). Recommendations for neonatal PIVC best practice are currently limited to cannula gauge size (Franck et al, 2001), fluids to avoid peripheral infusion (McCullen and Pieper, 2006), and consideration for PIVC complications (Legemaat et al, 2016;Tandale et al, 2017).…”

Section: Introductionmentioning

confidence: 99%

“…Practice surveys can be used to identify gaps in clinical practices and knowledge (Shah and Tracy, 2013), highlighting future directions for research and practice development. This study was undertaken to guide future direction of research by this research team.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Peripheral intravenous catheter practices in Australian and New Zealand neonatal units: A cross-sectional survey

August

Ullman

Rickard

et al. 2019

Journal of Neonatal Nursing

View full text Add to dashboard Cite

A B S T R A C TPeripheral intravenous catheters (PIVCs) are important tools for the provision of treatment for unwell and premature neonates. This study aimed to explore current PIVC practices (i.e. insertion, product selection, complications and management priorities) within Australian and New Zealand neonatal units, to identify areas for innovation and practice change. The survey was distributed via Australian and New Zealand neonatal nursing associations, with 180 respondents (54% Australia; 46% New Zealand). Respondents reported an average of 2-3 insertion attempts were required per PIVC, with variability in cleansing agents, decontamination techniques, skin barrier films and PIVC dressing products used. The large majority of respondents reported seeing skin complications associated with PIVCs within their practice (94%). Infection prevention was the highest management priority, and skin complication prevention, the lowest priority. High quality research is necessary to inform neonatal PIVC insertion and management practices, to improve patient safety and treatment provision. plications, and (d) PIVC management priorities.

show abstract

Section: Discussionmentioning

confidence: 55%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Peripheral intravenous catheter practices in Australian and New Zealand neonatal units: A cross-sectional survey

August

Ullman

Rickard

et al. 2019

Journal of Neonatal Nursing

View full text Add to dashboard Cite

show abstract

“…24 Another survey from Australia and New Zealand revealed aqueous CHG to be the most commonly used antiseptic in preterm population (72%) while the alcohol-based CHG to be the most used for full-term infants (56%). 11 Our high rate of skin burns among CHG-using units is not surprising. The local adverse effects of CHG in neonates are well known and were frequently reported in the literature especially in preterm infants.…”

Section: Discussionmentioning

confidence: 91%

Current Practices of Antiseptic Use in Canadian Neonatal Intensive Care Units

2018

View full text Add to dashboard Cite

show abstract

“…Nach nordamerikanischen Publikationen nimmt (trotz eines entsprechenden Warnhinweises der Food and Drug Administration zum Einsatz bei Kindern mit einem Lebensalter unter 2 Monaten) der Einsatz von CHX bei Frühgeborenen in den USA zu [117,[120][121][122][123][124]. Allerdings bestätigen diese Studien die transkutane Resorption von CHX bei Frühgebo-renen [125,126].…”

Section: Hautantisepsis Vor Invasiven Maßnahmenunclassified

Prävention von Gefäßkatheter-assoziierten Infektionen bei Früh- und Neugeborenen

2018

Bundesgesundheitsbl

View full text Add to dashboard Cite

Kategorie IADiese Empfehlung basiert auf gut konzipierten systematischen Reviews oder einzelnen hochwertigen randomisierten kontrollierten Studien. Kategorie IBDiese Empfehlung basiert auf klinischen oder hochwertigen epidemiologischen Studien und strengen, plausiblen und nachvollziehbaren theoretischen Ableitungen.Kategorie II Diese Empfehlung basiert auf hinweisenden Studien/Untersuchungen und strengen, plausiblen und nachvollziehbaren theoretischen Ableitungen. Kategorie IIIMaßnahmen, über deren Wirksamkeit nur unzureichende oder widersprüchliche Hinweise vorliegen, deshalb ist eine Empfehlung nicht möglich. Kategorie IVAnforderungen, Maßnahmen und Verfahrensweisen, die durch allgemein geltende Rechtsvorschriften zu beachten sind.

show abstract

Skin antisepsis survey in Australia–New Zealand neonatal nurseries

Cited by 17 publications

References 6 publications

Peripheral intravenous catheter practices in Australian and New Zealand neonatal units: A cross-sectional survey

Peripheral intravenous catheter practices in Australian and New Zealand neonatal units: A cross-sectional survey

Current Practices of Antiseptic Use in Canadian Neonatal Intensive Care Units

Prävention von Gefäßkatheter-assoziierten Infektionen bei Früh- und Neugeborenen

Contact Info

Product

Resources

About